Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    2.

    [Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].

    Mitter D, Ortmann O, Treeck O.

    Zentralbl Gynakol. 2005 Aug;127(4):228-34. Review. German.

    PMID:
    16037904
    [PubMed - indexed for MEDLINE]
    3.

    A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

    Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nisticò C, Fabi A, Buglioni S, Natali PG, Mottolese M.

    Breast Cancer Res. 2008;10(5):R74. Epub 2008 Sep 4.

    PMID:
    18771580
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.

    Rosa FE, Caldeira JR, Felipes J, Bertonha FB, Quevedo FC, Domingues MA, Moraes Neto FA, Rogatto SR.

    Hum Pathol. 2008 May;39(5):720-30. Epub 2008 Jan 30.

    PMID:
    18234277
    [PubMed - indexed for MEDLINE]
    5.

    Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

    Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.

    Breast Cancer Res. 2007;9(6):R77.

    PMID:
    17986353
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.

    Chu I, Arnaout A, Loiseau S, Sun J, Seth A, McMahon C, Chun K, Hennessy B, Mills GB, Nawaz Z, Slingerland JM.

    J Clin Invest. 2007 Aug;117(8):2205-15.

    PMID:
    17627304
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.

    Murillo-Ortiz B, Pérez-Luque E, Malacara JM, Daza-Benítez L, Hernández-González M, Benítez-Bribiesca L.

    Pathol Oncol Res. 2008 Dec;14(4):435-42. Epub 2008 Aug 28.

    PMID:
    18752050
    [PubMed - indexed for MEDLINE]
    8.

    Estrogen receptor-beta mRNA is associated with adverse outcome in patients with breast cancer.

    Markey GC, Cullen R, Diggin P, Hill AD, Mc Dermott EW, O'Higgins NJ, Duffy MJ.

    Tumour Biol. 2009;30(4):171-5. Epub 2009 Sep 9.

    PMID:
    19738412
    [PubMed - indexed for MEDLINE]
    9.

    Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers.

    Hamaguchi M, Nishio M, Toyama T, Sugiura H, Kondo N, Fujii Y, Yamashita H.

    Jpn J Clin Oncol. 2008 Nov;38(11):734-42. Epub 2008 Sep 26.

    PMID:
    18820009
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.

    Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM.

    Nucleic Acids Res. 2009 May;37(8):2584-95. Epub 2009 Mar 5.

    PMID:
    19264808
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

    Hosey AM, Gorski JJ, Murray MM, Quinn JE, Chung WY, Stewart GE, James CR, Farragher SM, Mulligan JM, Scott AN, Dervan PA, Johnston PG, Couch FJ, Daly PA, Kay E, McCann A, Mullan PB, Harkin DP.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1683-94. Epub 2007 Nov 13.

    PMID:
    18000219
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Prognostic significance of estrogen receptor Beta in epithelial hyperplasia of usual type with known outcome.

    Shaaban AM, Jarvis C, Moore F, West C, Dodson A, Foster CS.

    Am J Surg Pathol. 2005 Dec;29(12):1593-9.

    PMID:
    16327431
    [PubMed - indexed for MEDLINE]
    14.

    Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.

    Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W.

    Ann N Y Acad Sci. 2009 Feb;1155:132-40. Review.

    PMID:
    19250200
    [PubMed - indexed for MEDLINE]
    15.

    Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?

    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.

    APMIS. 2009 Sep;117(9):644-50.

    PMID:
    19703124
    [PubMed - indexed for MEDLINE]
    16.

    Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

    Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.

    Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401.

    PMID:
    18922159
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

    Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS.

    Mol Endocrinol. 2008 May;22(5):1032-43. Epub 2008 Feb 7.

    PMID:
    18258689
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures.

    Zhu Y, Wang A, Liu MC, Zwart A, Lee RY, Gallagher A, Wang Y, Miller WR, Dixon JM, Clarke R.

    Int J Oncol. 2006 Dec;29(6):1581-9.

    PMID:
    17089000
    [PubMed - indexed for MEDLINE]
    19.

    Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.

    Ho SM, Leung YK, Chung I.

    Ann N Y Acad Sci. 2006 Nov;1089:177-93. Review.

    PMID:
    17261766
    [PubMed - indexed for MEDLINE]
    20.

    COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells.

    Le Dily F, Métivier R, Guéguen MM, Le Péron C, Flouriot G, Tas P, Pakdel F.

    Breast Cancer Res Treat. 2008 Jul;110(1):69-83. Epub 2007 Aug 3.

    PMID:
    17674191
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk